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Abstract
Background: Populations living in the area of the Mediterranean Sea suffered by decreased incidence of cancer
compared with those living in the regions of northern Europe and US countries, attributed to healthier dietary
habits. Nowadays, we are assisting to a moving away from the traditional Mediterranean dietary pattern, but
whether this changing is influencing risk of cancers is still unclear. The aim of the study was to review recent
evidence on potential relationship between the adherence to the Mediterranean diet and cancer.
Discussion: The most recent pooled analyses of epidemiological studies supported strongly the hypothesis that
the Mediterranean diet may play a role in preventing several types of cancers, especially those of digestive tract,
whereas contrasting results were reported for hormone-dependent cancers. Specific aspects of the Mediterranean
diet such as high fruit and vegetables and low red processed meat intake may explain such protective effects.
Moreover, evidence regarding olive oil and whole grains increase the beneficial effects of such dietary pattern
against cancer.
Conclusions: Literature evidence actually demonstrates that the increased adherence to the Mediterranean dietary
pattern is beneficial to health across populations and may translate a protective effect with certain cancers.
Background
Nowadays, the advent of improved screening programs
and surgical therapeutic approaches have positively
affected survival from many cancers [1-3]. On the other
hand, differences according non-modifiable and modifiable
factors may affect both stage at diagnosis, comorbidity
status, and survival [4,5]. Despite the global cancer burden,
only few cancers are genetically determined and the most
of cancer genesis and promotion mechanisms depends on
environmental factors [6-10]. It has been estimated that
many of the cancers occurring today are preventable by
applying preventive interventions derived by knowledge
that we already have [11]. The selective geographical loca-
lization of higher incidence rates of many types of cancers
in Western countries is attributable to factors related to
voluntary behaviors such as nutrition and physical activity
habits [12]. Historically, populations living in the area of
the Mediterranean Sea suffered by decreased incidence of
cancer compared with those living in the regions of north-
ern Europe and US countries [13]. This singular condition
has been attributed to the traditional dietary pattern com-
monly used by populations living in this area, which has
been recognized to protect also from cardiovascular dis-
eases [14]. The Mediterranean diet consists of: (i) fruits,
cooked vegetables and legumes, wholegrain and unrefined
cereals, (ii) olive oil as primary source of dietary lipids,
(iii) nuts, (iv) a moderate intake of wine, especially during
meals with fish and seafood, dairy products and eggs
finally (v) a low consumption of red meat and sweets.
Despite a general definition of the Mediterranean diet may
be given, there is no univocal pattern, since a variation
among countries exist. The studies conducted to estimate
the effects on health of the Mediterranean diet aimed to
consider the diet preferably as a whole nutrition pattern
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rather than referring to the single components of the diet,
enhancing the role of interactions between the multiple
components of the diet. Nowadays, we are assisting to a
moving away from the traditional dietary pattern in these
regions, generating several variations of the original pat-
tern, or even a “Westernization” of the diet due to the
modernization of the urban areas and a globalization of
the lifestyle, including diet. Despite a decrease in the
adherence to the Mediterranean diet in Mediterranean
countries during the last decades has been observed [15],
whether this changing in dietary and lifestyle patterns are
influencing risk of cancers is still unclear. Studying cancer
causes is challenging because increased risk of disease
does not only depend on factors related to diet, rather to
lifestyle and cultural models of a population. Moreover,
due to the long latent period for a malignancy to develop,
identify the specific associations between such factors and
cancer over a lifetime is difficult. However, accurate litera-
ture reviews may help to point-out hypotheses on poten-
tial relationship between lifestyle factors such as dietary
habits, and cancer. Evidence from epidemiological studies
may provide support to public health recommendations
and policies.
Evidence from epidemiological studies
In the past decades, evidence on the health effects of the
Mediterranean diet has been reported in many different
cohort studies by suggesting its possible protective role
against neoplastic diseases. A recent meta-analysis of
prospective cohort studies by Sofi et al. [16] concluded
that the Mediterranean diet is responsible of a 6%
reduction from death and/or the incidence of neoplastic
diseases (cancer incidence or mortality RR 0.94; 95% CI:
0.92, 0.96). Updated reports from a large cohort such as
the European Prospective Investigation Into Cancer and
nutrition including 335,873 individuals have found a
lower overall cancer risk among those with greater
adherence to Mediterranean diet (HR 0.96, 95% CI
0.95,0.98) for a two-point increment of the Mediterra-
nean diet score [17]. The apparent inverse association
was stronger for smoking-related cancers than for can-
cers not known to be related to tobacco. In all, 4.7% of
cancers among men and 2.4% in women would be
avoided in this population if study subjects had a greater
adherence to Mediterranean dietary pattern. However,
no data was given for specific cancer risk.
More recent epidemiological studies focused on associa-
tion between the Mediterranean diet and incidence of spe-
cific malignancies, the most of them regarding colorectal
and breast cancers. Regarding colorectal cancer, an a study
conducted on 45,275 participants of the Italian section of
the EPIC study followed for a mean of 11.28 years, the
Italian Mediterranean Index was inversely associated with
cancer risk (HR 0.50, 95% CI: 0.35, 0.71 for the highest
category compared to the lowest, P-trend: 0.043). Results
did not differ by sex. Highest Italian Mediterranean Index
score was also significantly associated with reduced risks
of any colon cancer (HR 0.54, 95% CI: 0.36, 0.81), distal
colon cancer (HR 0.44, 95% CI: 0.26, 0.75) and rectal can-
cer (HR 0.41, 95% CI: 0.20, 0.81), but not of proximal
colon cancer [18]. In the large cohort of 492,382 subjects
belonging to the National Institutes of Health-AARP Diet
and Health Study that the MD decreased colorectal cancer
risk in males (RR 0.72, 95% CI: 0.63, 0.83) was observed,
whereas no association in females was reported [19]. Simi-
lar results were found in another study conducted on
32,415 subjects included in the contest of the Prostate,
Lung, Colorectal, and Ovarian (PLCO) Cancer Screening
Trial which assessed that the Mediterranean dietary pat-
tern was associated with reduced risk of colorectal ade-
noma, especially in men (overall colorectal adenoma OR
0.79, 95% CI: 0.68, 0.92) [20]. On the contrary, a study
conducted on a total of 87,256 women and 45,490 men
followed for ≤ 26 years found no association with adher-
ence to the Mediterranean Cancer and protection from
colorectal cancer [21].
An investigation conducted among the women
included in the EPIC cohort showed that adherence to a
Mediterranean diet excluding alcohol was related to a
modest reduced risk of breast cancer in postmenopausal
women, and this association was stronger in receptor-
negative tumors [22]. Similar findings have been reported
in 33,731 women from the UK Women’s Cohort Study
with a non-significant inverse association with increasing
adherence to the Mediterranean diet pattern in premeno-
pausal but not postmenopausal women [23] whereas a
marginally significant inverse association (HR 0.78 for
every 2 points, 95% CI: 0.62, 0.98) among postmenopau-
sal women in the Greek arm of the EPIC study was
found [24]. Moreover, although the Minnesota Breast
Cancer Family Study did not find an association between
MD and breast density, a stratified analysis identified a
protective role of the Mediterranean diet among current
smokers (beta = -1.68, P = 0.002) but not among non-
smokers (beta = -0.08, P = 0.72; P for interaction = 0.008)
[25]. The study of the histological features of the breast
cancer observed leaded to contrasting results. Fung et al.
observed no association between the diet quality indices
and total or positive estrogen receptor (ER+) breast can-
cer risk with postmenopausal women who scored high in
MD adherence score had a lower risk of negative estro-
gen receptor (ER-) breast cancer (OR 0.79 95% CI: 0.60-
1.03) [26]. Contrarily, a French study reported an
increase of breast cancer risk with the Western diet for
ER+/positive progesterone receptor (PR+) tumors (HR
1.20, 95% CI: 1.03-1.38), and a negative association of the
MD for breast cancer risk (HR 0.85, 95% CI: 0.75-0.95),
especially for ER+/PR- tumors [27].
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Among the other cancer incidences explored within
large epidemiological prospective cohort studies, some
investigation regarded prostate, gastric, and endometrial
cancers. A study aimed to explore the association
between adherence to a relative Mediterranean diet and
incident gastric adenocarcinoma within the EPIC cohort
reported that a 1-unit increase in the Mediterranean
diet score was associated with a decreased risk of cancer
of 5% (95% CI: 0.91, 0.99) [28]. No significant associa-
tion was also observed between a Mediterranean diet
and total prostate cancer or between any of the indices
and advanced or fatal prostate cancer in a cohort of
293,464 US men in the National Institutes of Health
(NIH)-AARP Diet and Health Study [29]. In individual
component analyses, the fish and ω-3 fatty acids were
inversely associated with fatal prostate cancer (HR =
0.79, 95% CI: 0.65, 0.96, and HR = 0.94, 95% CI: 0.90,
0.98, respectively). Regarding the incidence of endome-
trial cancer, a study conducted in San Francisco on
woman aged 35-79 showed that a greater consumption
of the Western diet was associated with a 60% increase
in the risk cancer but no association with endometrial
cancer was found with the Mediterranean diet [30].
The association between the Mediterranean diet and
cancer has been studied in a series of case-control studies
conducted on breast, colon, and upper aero-digestive
tract cancers [31-33]. The one of Demetriou et al. [31]
did not report any association between breast cancer and
Mediterranean diet, although higher consumptions of
vegetables, fish and olive oil, were independently asso-
ciated with decreased risk of disease. Contrarily, a study
including two case-control groups of Hispanic (757 cases,
867 controls) and non-Hispanic white women (1524
cases, 1598 controls) from the Four-Corners Breast
Cancer Study reported that the Mediterranean dietary
patterns were associated with lower risk of breast cancer
(OR 0.76, 95% CI: 0.63, 0.92) [34]. Another series of stu-
dies focused on the mediating effect of Mediterranean
diet on a variety of lifestyle behaviors and colorectal can-
cer, have found that increase in the adherence to the
Mediterranean diet was associated with lower likelihood
of colorectal cancer whereas a positive association with
alcohol intake and smoking habit was reported [32,33].
Finally, the study conducted in the context of the Eur-
opean alcohol-related cancers and genetic susceptibility
in Europe project, reported that stricter adherence to the
Mediterranean diet was associated with a substantial and
significant decrease in UADT cancer risk (30 % for a
two-unit increase in score) [35], confirming results of a
work reporting data from three case-control studies con-
ducted in Italy between 1992 and 2000 in which an OR
of 0.40 for oral and pharyngeal, 0.26 for esophageal, and
0.23 for laryngeal cancer in subjects more adherent to
the Mediterranean dietary pattern was found [36].
Selected components of Mediterranean diet
protecting against cancer
Fruit and vegetables
The role of the main components of the Mediterranean
diet in several common epithelial cancers, including
digestive and selected non-digestive tract neoplasms,
have been showed in a report of La Vecchia [37] review-
ing a series of case-control studies conducted in Italy
between 1983 and 1998 over 12,000 cases of 20 cancer
sites and 10,000 controls. The relative risk (RR) for
most epithelial, digestive tract, breast, female genital
tract, urinary tract cancers was decreased with increas-
ing vegetable and fruit consumption, probably due to
the beneficial effects of a number of antioxidants and
other micronutrients which showed themself an inverse
relationship with cancer risk [38].
Raw and fresh vegetables, leafy green vegetables, cruci-
ferous vegetables, carrots, broccoli, cabbage, lettuce, and
raw and fresh fruit (including citrus fruit and tomatoes)
appear to be protective against cancer due to their high
content of antioxidants compounds, such as carotenoids,
vitamin C, vitamin E, selenium, dietary fiber (and its com-
ponents), dithiolthiones, glucosinolates (isothiocyanates
and indoles), polyphenols, protease inhibitors, allium com-
pounds, plant sterols, and limonene [39,40]. A high intake
of glucosinolate-containing cruciferous vegetables, such as
Brussels sprouts (Brassica oleraceae), has been linked to a
decreased cancer risk [41]. Indoles and isothiocyanates,
two major groups of glucosinolate breakdown products,
attenuate the effects of polycyclic aromatic hydrocarbons
(PAHs) and nitrosamines under experimental conditions
[42]. In addition, indole-3-carbinol (I3C), a naturally
occurring component of Brassica vegetables, such as
broccoli, cabbage, and Brussels sprouts, has been found to
prevent the progression of different cancers and in parti-
cularly induces a G(1) cell-cycle arrest of human breast
cancer cells. Moreover, indole-3-carbinol (I3C) has signifi-
cant therapeutic potential for treatment of human cancers
associated with high levels of elastase [43]. This anti-
tumoral effect is expressed by a noncompetitive inhibition
of elastase enzymatic activity. Indeed, high accumulation
of cyclin E protein is associated with cancer cell prolifera-
tion, poor clinical outcomes, decreased response to che-
motherapy, reduced response to endocrine treatment and
a reduced survival rate in some human cancers [44].
Citrus fruit, especially blond and red oranges (Citrus
sinensis), contains a high amount of antioxidant compo-
nents including polyphenols, flavanones, anthocyanins,
hydroxycinnamic acids, and ascorbic acid (depending on
the variety of fruit) [45]. Laboratory studies have showed
that citrus flavonoids and anthocyanins are able to inhi-
bit the growth of several tumors, including breast and
colorectal cancer [46,47] through inhibiting multiple
cancer-related biological pathways, such as carcinogen
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bio-activation, cell-signaling, cell cycle regulation, angio-
genesis, and inflammation [48,49]. Citrus flavonoids
have been hypothesized to inhibit the matrix metallo-
proteinase (MMP) secretion, migration, invasion and
adhesion [50-52], and to have pro-apoptotic activity
[53-56].
Tomatoes are undergoing particular attention because
they clearly characterize the Mediterranean diet. Eating
tomatoes has been associated with reduced risks of some
types of cancer and other diseases [57]. Their constitu-
ents such as carotenoids and flavonoids contribute to the
prevention of ultra violet ray damage in humans [58] and
are efficient antioxidants capable of scavenging reactive
oxygen species generated under conditions of photo-
oxidative stress [59]. Lycopene, red pigment present in
many red fruits and vegetables, is the major carotenoid of
the tomato and is a very efficient singlet oxygen quencher
in the group of carotenoids [58]. Tomatoes and related
tomato products are the major source of lycopene com-
pounds, and are also considered an important source of
carotenoids in the human diet. Industrial and thermal
processing (bleaching, retorting, and freezing processes)
generally causes some loss of lycopene in tomato-based
foods, although lycopene bioavailability in processed
tomato products is higher than in unprocessed fresh
tomatoes [60]. Food processing may improve lycopene
bioavailability by breaking down cell walls, which weak-
ens the bonding forces between lycopene and tissue
matrix, thus making lycopene more accessible [61]. Sup-
plementation of tomato products, containing lycopene,
has been assessed to have similar effects on health than
consuming tomato. Indeed, such products supplementa-
tion lower biomarkers of oxidative stress and carcinogen-
esis [62] and protect the skin against UVR-induced
effects (i.e., erythema) [63,64]. Moreover, tomato extract
has been shown to ameliorate tissue damage, to decrease
the risk of many chronic diseases including several types
of cancer (i.e., prostate cancer) [65,66]. Purple tomatoes,
highly enriched with anthocyanins, have been shown to
prolong life under experimental conditions suggesting
that they have additional health-promoting effects [67].
Fish vs. meat
Frequent fish intake has been related to decreased risk of
several neoplasms whereas red meat intake demonstrated
detrimental effects, especially increasing the risk of color-
ectal cancer [68], through production of N-nitroso
compounds and, when cooked at high temperatures, het-
erocyclic amines and polycyclic aromatic hydrocarbons
(which are known carcinogens) [69]. Red meat and pro-
cessed meat intake has been hypothesized to increase
breast cancer risk but while both case-control and ecolo-
gic studies have supported a positive association, pro-
spective cohort studies have been inconsistent [70].
Further investigations of potential effect modifiers, such
as analyses by hormone receptor or menopausal status,
may provide valuable insight to potential patterns of
associations. Indeed, a meta-analysis including only stu-
dies conducted on premenopausal women demonstrated
a pooled RR of 1.24 (95% CI 1.08, 1.42) [71]. Among the
more evident associations, meat and processed meat
intake has been related with esophageal [72,73], lung
[74], pancreatic [75], bladder [76] cancers, whereas
inconclusive results were reported for prostate [77],
kidney [78], and ovarian [79] cancers.
Whole-grain
Consumption of refined and whole grains, in form of
bread, pasta, and rice, is a major characteristic of MD
and has been associated with reduced cancer risk, includ-
ing those of the upper aero-digestive tract, stomach, col-
orectum, liver, breast, ovary, bladder and kidney [80],
while refined grain intake was associated with an
increased risk of stomach, colorectal, upper aero-diges-
tive tract and thyroid cancers [81]. The beneficial role of
whole-grain has been hypothesized to be due to their
high content of fibres, which OR of colon and rectal can-
cers were below unity for high intakes of most types of
dietary fibres, especially those contained in rice [82],
whereas no appreciable differences emerged between the
two sites [83-85]. Nevertheless, high intakes of most
types of dietary fibres have been associated with lower
odds also for upper aero-digestive tract neoplasms
[86,87]. Dietary fibers may act on cancer risk by improv-
ing faecal bulking and satiety, viscosity and short chain
fatty acid production, enhancing fermentation of metabo-
lites. Fibres may protect from colorectal cancer by
increasing stool bulk, thus reducing transit time and con-
tact of carcinogens with the colonic mucosa or by acting
as probiotic, namely a nondigestible food ingredient
whose beneficial effects on the host result from the selec-
tive stimulation of growth and/or activity of members of
the bacterial community that inhabits the human bowel
[88]. The fermentation of dietary fibre by the microflora
enhances the levels of effective metabolites which are
potentially protective against colon cancer inhibiting cell
growth and promoting apoptosis as well as differentiation
[89,90].
Another hypothesis investigated on the possible
mechanism of cancer promotion related to refined and
whole grain foods, was their connection with the dietary
glycaemic index (GI) (an indicator of the rate of adsorp-
tion of carbohydrates and, hence, a measure of insulin
demand) and glycaemic load (GL) (which combines the
quality as well as the quantity of carbohydrate consumed).
Both GI, and in particular GL, have been suggested to be
relevant factors in the cancer incidence due to the poten-
tial role of insulin and insulin grow factor (IGF) in cancer
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promotion [91,92]. With reference to digestive tract can-
cers, there was a direct association of colon and gastric
cancer with such indices; among female hormone-related
neoplasms, direct associations with breast, ovarian and
endometrial cancers; among upper aero-digestive tract
neoplasms, an association was found for those of the oral
cavity/pharynx, esophagus and larynx; finally, a significant
association was found for thyroid and prostate cancers
[84]. Results of recent meta-analyses of prospective cohort
studies reported a pooled RR for all diabetes-related can-
cers of 1.07 (95% CI: 1.04, 1.11) for GI and 1.02 (95% CI:
0.96, 1.08), whereas the analysis of site-specific cancer
risks revealed a significant associations for GI in relation
to breast cancer (RR 1.06, 95% CI: 1.02, 1.11) and colorec-
tal cancer (RR 1.08, 95% CI:1.00, 1.17) and for GL to endo-
metrial cancer (RR 1.21, 95% CI: 1.07, 1.37) [93] whereas
no significant risk of digestive tract neoplasms was found
[94]. The role of fibre in preventing chronic disease also
depends on their numerous bioactive compounds with
antioxidant and anti-carcinogenic properties, especially
those in the bran and germ (minerals, trace elements, vita-
mins, carotenoids, polyphenols and alkylresorcinols), the
properties of which have been described above. Whole-
grain wheat is also a rich source of methyl donors and
lipotropes (methionine, betaine, choline, inositol and
folates) that may be involved in cardiovascular and hepatic
protection, lipid metabolism and DNA methylation [95].
Olive oil
The association of olive oil and other mono- and unsa-
turated fats with many types of cancer has been
reviewed, reporting a favorable effect on breast, ovarian,
colorectal, but mostly of upper aero-digestive tract can-
cers [84]. A recent meta-analysis of 13800 patients and
23340 controls in 19 observational studies concluded
that higher intake of olive oil intake was associated with
lower odds of having any type of cancer (log OR -0.41,
95% CI: -0.53, -0.29), breast cancer (log OR -0.45, 95%
CI: -0.78, -0.12), and a cancer of the digestive system
(log OR -0.36, 95% CI: -0.50, -0.21), compared with the
lowest intake [96]. Experimental and human cellular stu-
dies have provided new evidence on the potential pro-
tective effect of olive oil on certain cancers such as
breast, colorectal and prostate cancers [97]. Olive oil has
been suggested to inhibit colon cancer development by
inducing apoptosis in large intestinal cancer cells and
down-regulating the expression of cyclooxygenase 2
(COX-2) and Bcl-2 proteins that have a crucial role in
colorectal carcinogenesis [98]. Among its potentially
health-promoting components, tyrosol and hydroxytyro-
sol have been demonstrated to decrease glutathione
(GSH), the activation of the transcription factor Nuclear
Factor-B and cell death which may be implicated in
the carcinogenetic processes [99].
Red wine
Wine, especially red wine, is rich in several plant com-
pounds with a wide range of health properties. Whether
moderate intake of red wine may protect against cancer
is still controversial [100]. Many of the beneficial prop-
erties of red wine depend on its content of resveratrol
(3,4’,5-trihydroxy-trans-stilbene), a phytoalexin found
also in grape skins, peanuts and berries, that may act as
an antioxidant and cancer chemopreventive agent
thanks to its ability of inhibiting tumor initiation, pro-
motion, and progression [101]. Indeed, several studies
have shown that resveratrol and some of its analogs
interfere with signal transduction pathways, modulate
cell cycle-regulating proteins, and are a potent inducer
of apoptosis in multiple carcinoma cell lines [102].
Recently, the chemopreventive properties of resveratrol
have been associated with the inhibition of Nuclear
Factor-kB activity [103]. In addition, resveratrol exhibits
anti-inflammatory, growth-inhibiting activity and immu-
nomodulation properties [104]. Interestingly, the afore-
mentioned health benefits of resveratrol against cancer
produced in the laboratory setting cannot be translated
in effects on free-living population. Indeed, some cohort
studies conducted on lung [105], colorectal [106], and
prostate [107] cancers, reported that red wine does not
contribute appreciably to the etiology or protection of
such malignancies. It may be speculated that the benefi-
cial effects of antioxidant compounds contained in red
wine may be offset by the detrimental effects of alcohol.
Conclusions
Several aspects of the MD may lead to some health bene-
fits that reflect a higher survival and a lower incidence of
cancer. However, limitations of literature studies have to
be considered. Firstly, studies exploring the adherence to
the MD and cancer incidence or mortality, have a metho-
dological limitation due to the longer follow-up period,
during which the latency of dietary influences on the risk
of death may be influenced by changes in dietary habits,
if diet is assessed at enrolment and if a cumulative expo-
sure to a more or less healthy diet is considered. More-
over, some further confounding factors such as, the effect
of dietary supplements, may lead to sure bias if studies
do not control or results are not adjusted for these vari-
ables. Finally, possible measurement error and recall bias
should be taken in to account. Another limitation of
some studies is the availability of information on non-
dietary variables such as socioeconomic and cultural
status. In fact, the only variable taken in account was the
latest educational achievement which is both objectively
ascertainable and internationally applicable, but it is not
comprehensive of other factors influencing the lifestyle.
Another non-dietary factor that should be considered
in these kinds of studies and is often missing or not
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homogeneously measured is the physical activity level. In
fact physical activity is an independent risk factor for
many types of cancer. Despite these limitations, literature
evidence actually demonstrates that the increased adher-
ence to the Mediterranean dietary pattern is beneficial to
health across populations and may translate a protective
effect with certain cancers.
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